1. Home
  2. UK vs PPCB Comparison

UK vs PPCB Comparison

Compare UK & PPCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ucommune International Ltd

UK

Ucommune International Ltd

HOLD

Current Price

$2.98

Market Cap

2.5M

ML Signal

HOLD

PPCB

Propanc Biopharma Inc.

HOLD

Current Price

$0.09

Market Cap

2.3M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
UK
PPCB
Founded
2015
2007
Country
China
Australia
Employees
42
2
Industry
Business Services
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.5M
2.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
UK
PPCB
Price
$2.98
$0.09
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
341.0K
5.8M
Earning Date
03-24-2026
05-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.24
$0.09
52 Week High
$5.90
$10.69

Technical Indicators

Market Signals
Indicator
UK
PPCB
Relative Strength Index (RSI) 71.40 34.44
Support Level $0.75 N/A
Resistance Level N/A $0.13
Average True Range (ATR) 0.57 0.01
MACD 0.27 0.00
Stochastic Oscillator 50.36 8.10

Price Performance

Historical Comparison
UK
PPCB

About UK Ucommune International Ltd

Ucommune International Ltd is a flexible office space provider and manager based in the People's Republic of China (PRC). The company offers long-term leasing, on-demand, and short-term leasing solutions to freelancers, start-up entrepreneurs, small and medium enterprises, and corporations. Company provide fully-serviced and well-furnished office spaces on a flexible basis. The members of the Ucommune community, which includes individuals and enterprises registered on the U bazaar mobile app, can avail of these services. The company has three operating segments: Workspace membership, and Other services. The Workspace membership segment generates the majority of the company's revenue.

About PPCB Propanc Biopharma Inc.

Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.

Share on Social Networks: